温敏可注射原位交联水凝胶包裹BMSCs与TGF-β1修复兔半月板缺损
本研究在兔半月板临界尺寸缺损模型中,评估温敏可注射原位交联水凝胶的生物相容性,并比较负载BMSCs的水凝胶是否联合TGF-β1能促进纤维软骨分化和半月板修复。结果显示联合TGF-β1可促进BMSCs增殖与纤维软骨分化,并显著改善组织学愈合评分。
要点
- 水凝胶弹性模量约1000 Pa,具有缓释性能。
- 联合TGF-β1可促进BMSCs增殖与纤维软骨分化(P < .001)。
- 联合组Ishida评分5.00 ± 0.71,高于单纯水凝胶组和PBS组。
核心结论
- 该水凝胶具有生物相容性,联合TGF-β1后可强烈刺激BMSCs向纤维软骨分化。
- 局部应用负载BMSCs并整合TGF-β1的水凝胶可促进兔半月板损伤愈合。
研究设计与样本
- 控制性实验室研究,体外评估水凝胶流变学与缓释性能及BMSCs行为,体内在30只兔半月板建立临界尺寸缺损。
主要发现
- 水凝胶弹性模量约1000 Pa,具有缓释性能。
- 联合TGF-β1后水凝胶可促进BMSCs增殖并诱导纤维软骨分化(P < .001)。
- 术后8周,BMSC+TGF-β1组缺损区可见大量番红O染色阳性、II型胶原强表达且I型胶原弱表达的纤维软骨组织。
- BMSC水凝胶组缺损区填充纤维组织及少量纤维软骨。
- 三组Ishida定量评分分别为PBS组1.00、BMSC水凝胶组3.20 ± 0.84、BMSC+TGF-β1水凝胶组5.00 ± 0.71(P < .001)。
关键数值与推荐
- Ishida评分系统用于定量评价愈合,PBS组1.00、BMSC水凝胶组3.20 ± 0.84、BMSC+TGF-β1水凝胶组5.00 ± 0.71(P < .001)。
临床怎么用
- 该水凝胶可作为半月板组织工程的替代支架,联合BMSCs与TGF-β1可能促进半月板缺损修复。
局限性
- 原文未报告局限性相关内容。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Meniscal injury repair with tissue engineering technique is promising. Among various scaffolds, the thermosensitive injectable hydrogel has recently attracted much attention. PURPOSE: (1) Evaluate the biocompatibility of thermosensitive, injectable, in situ crosslinked hydrogel and (2) determine whether the hydrogel with or without transforming growth factor β1 (TGF-β1) could support the fibrochondrogenic differentiation of bone mesenchymal stromal cells (BMSCs) and promote the repair of a critical-sized defect in rabbit meniscus. STUDY DESIGN: Controlled laboratory study. METHODS: The rheological and sustained release properties of the hydrogel were demonstrated. BMSCs were isolated and cultured. Cell viability, quantitative polymerase chain reaction (qPCR), and Western blot were tested in vitro. In vivo, a critical-sized defect was introduced into the meniscus of 30 rabbits. Each defect was randomly assigned to be implanted with either phosphate-buffered saline (PBS); BMSC-laden hydrogel; or BMSC-laden, TGF-β1-incorporated hydrogel. Histological and immunohistochemical analyses were performed at 8 weeks after surgery. The Ishida scoring system was adopted to evaluate the healing quantitatively. RESULTS: The elastic modulus of the hydrogel was about 1000 Pa. The hydrogel demonstrated a sustained-release property and could promote proliferation and induce fibrochondrogenic differentiation of BMSCs after the incorporation of TGF-β1 (P < .001). At 8 weeks after surgery, a large amount of fibrocartilaginous tissue, which was positive on safranin-O staining and expressed strong type II collagen intermingled with weak type I collagen, was observed in the defect region of the BMSC-laden, TGF-β1-incorporated hydrogel group. In the BMSC-laden hydrogel group, the defect was filled with fibrous tissue together with a small amount of fibrocartilage. The mean ± SD quantitative scores obtained for the 3 groups-PBS; BMSC-laden hydrogel; and BMSC-laden, TGF-β1-incorporated hydrogel-were 1.00, 3.20 ± 0.84, and 5.00 ± 0.71, respectively (P < .001). CONCLUSION: The hydrogel was biocompatible and could stimulate strong fibrochondrogenic differentiation of BMSCs after the incorporation of TGF-β1. The local administration of the BMSC-laden, TGF-β1-incorporated hydrogel could promote the healing of rabbit meniscal injury. CLINICAL RELEVANCE: This hydrogel is an alternative scaffold for meniscus tissue engineering.
引用
- Chen C, Song J, Qiu J, et al. Repair of a Meniscal Defect in a Rabbit Model Through Use of a Thermosensitive, Injectable, In Situ Crosslinked Hydrogel With Encapsulated Bone Mesenchymal Stromal Cells and Transforming Growth Factor β1. Am J Sports Med. 2020. PMID: 31967854. doi:10.1177/0363546519898519
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。